Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective Effect of Ketamine-Dexmedetomidine vs Fentanyl-Midazolam in Pediatric Open-Heart Surgery
NCT05314569Phase 1Completed
- Sponsor
- Cairo University
- Start
- Apr 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine and dexmedetomidine in myocardial reperfusion injury (3 arms), sponsored by Cairo University. Primary endpoint: Troponin level at 6 hours. Started Apr 2022; status: completed.
02
Drugs
ketaminedexmedetomidine
03
Conditions
myocardial reperfusion injury
Beyond the preview
Go deeper on NCT05314569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05314569.